Frontlight ResearchEarly access
Trial site
Memorial Cancer Institute
- 9running trials
- 1closed trial
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia3 trials
- Lung cancer3 trials
- Prostate cancer2 trials
- Sarcoma2 trials
- Bladder cancer1 trial
- Cervical cancer1 trial
- Colorectal cancer1 trial
- Gastric and oesophageal cancer1 trial
- Kidney cancer1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple myeloma1 trial
- and 2 more
- Phase
- Phase 36 trials
- Phase 1/22 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting5 trials
- Active, not recruiting4 trials
- Terminated1 trial
- Lead sponsor
- Janssen Research & Development, LLC4 trials
- Amgen1 trial
- Astellas Pharma Global Development, Inc.1 trial
- Eli Lilly and Company1 trial
- Gilead Sciences1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)
Active, not recruiting
A Study of Abemaciclib (LY2835219) in Participants With Previously Treated KRAS Mutated Lung Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Lung cancer1 recruiting
- Multiple myeloma1 recruiting
- Prostate cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026